米诺环素经Sonic Hedgehog信号与凋亡免疫调节并直接抗耐药结核
该研究在实验室菌株、30株药物敏感及耐多药/广泛耐药临床菌株和空心纤维系统模型中评估米诺环素抗结核活性。结果显示临床可达浓度下菌株敏感,7 mg/kg/day人等效剂量杀菌率与一线抗结核药相当;米诺环素直接杀胞外菌,经浓度依赖性颗粒酶A驱动凋亡间接杀胞内菌,并剂量依赖性抗炎、下调细胞外基质重塑通路及抑制Sonic Hedgehog-Patched-Gli信号。
要点
- 米诺环素在临床可达浓度下对30株药物敏感及耐多药/广泛耐药结核临床菌株敏感。
- 空心纤维模型中7 mg/kg/day人等效剂量杀菌率与一线抗结核药相当。
- 米诺环素直接杀胞外菌,经颗粒酶A驱动凋亡间接杀胞内菌,并剂量依赖性抗炎。
核心结论
- 米诺环素对药物敏感及耐药结核分枝杆菌有直接杀菌活性,并可通过颗粒酶A驱动凋亡和抑制Sonic Hedgehog信号发挥双相免疫调节。
研究设计与样本
- 研究评估米诺环素对实验室结核分枝杆菌株及30株药物敏感和耐多药/广泛耐药临床株的敏感性。
- 采用空心纤维系统模型模拟7 mg/kg/day人等效剂量米诺环素的肺浓度-时间曲线。
- 对空心纤维系统重复样本行RNA测序,并开展独立蛋白丰度实验。
主要发现
- 30株药物敏感和耐多药/广泛耐药临床株对临床可达浓度米诺环素敏感。
- 空心纤维系统中7 mg/kg/day人等效剂量米诺环素杀菌率与一线抗结核药相当。
- 米诺环素直接杀灭胞外菌,并经浓度依赖性颗粒酶A驱动凋亡间接杀灭胞内菌。
- 米诺环素呈剂量依赖性抗炎活性并下调细胞外基质重塑通路。
- RNA测序和蛋白丰度实验显示米诺环素剂量依赖性抑制Sonic Hedgehog-Patched-Gli信号。
临床怎么用
- 米诺环素可能作为药物敏感及耐药潜伏和活动性结核的双重免疫调节与直接杀菌治疗缩短方案的候选药物。
- 其抗炎及下调细胞外基质重塑通路的作用可能保护患者免于结核免疫病理损伤并改善肺重塑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drug-resistant tuberculosis represents a global emergency, requiring new drugs. We found that minocycline was highly potent in laboratory strains of Mycobacterium tuberculosis and that 30 drug-susceptible and multidrug/extensively drug-resistant clinical strains were susceptible to clinically achievable concentrations. In the hollow fiber system model, lung concentration-time profiles of 7 mg/kg/day human-equivalent minocycline dose achieved bacterial kill rates equivalent to those of first-line antituberculosis agents. Minocycline killed extracellular bacilli directly. Minocycline also killed intracellular bacilli indirectly, via concentration-dependent granzyme A-driven apoptosis. Moreover, minocycline demonstrated dose-dependent antiinflammatory activity and downregulation of extracellular matrix-based remodeling pathways and, thus, could protect patients from tuberculosis immunopathology. In RNA sequencing of repetitive samples from the hollow fiber system and in independent protein abundance experiments, minocycline demonstrated dose-dependent inhibition of sonic hedgehog-patched-gli signaling. These findings have implications for improved lung remodeling and for dual immunomodulation and direct microbial kill-based treatment shortening regimens for drug-susceptible and drug-resistant latent and active M. tuberculosis infection.
引用
- Deshpande D, Pasipanodya JG, Srivastava S, et al. Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis. J Infect Dis. 2019. PMID: 30597040. doi:10.1093/infdis/jiy587
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。